Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs

W. Guo, R. Liu, Y. Ono, A.-H. Ma, A. Martinez, E. Sanchez, Y. Wang, W. Huang, A. Mazloom, J. Li, J. Ning, E. Maverakis, K.S. Lam, H.-J. Kung

Research output: Contribution to journalArticle

17 Citations (Scopus)

Fingerprint Dive into the research topics of 'Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs'. Together they form a unique fingerprint.

Medicine & Life Sciences